Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Cosmi

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
European Journal of Immunology|April 8, 2017
Th17 and Treg lymphocytes as cellular biomarkers of disease activity in Granulomatosis with PolyangiitisLorenzo Cosmi
American Journal of Respiratory and Critical Care Medicine|May 6, 2017
Group 2 Innate Lymphoid Cells Are the Earliest Recruiters of Eosinophils in Lungs of Patients with Allergic AsthmaLorenzo Cosmi, Francesco Annunziato
International Journal of Molecular Sciences|October 13, 2021
From Emollients to Biologicals: Targeting Atopic DermatitisLorenzo Salvati, Lorenzo Cosmi, Francesco Annunziato
Current Opinion in HIV and AIDS|June 15, 2010
Human and murine Th17Francesco Annunziato, Lorenzo Cosmi, Sergio Romagnani
Journal of Psychosomatic Research|October 16, 2025
The fibromyalgia black boxSara Ceccatelli, Lorenzo Cosmi, Fiammetta Cosci
Current Opinion in Allergy and Clinical Immunology|November 25, 2015
Th17 regulating lower airway diseaseLorenzo Cosmi, Francesco Liotta, Francesco Annunziato
Current Allergy and Asthma Reports|September 13, 2017
Role of Type 2 Innate Lymphoid Cells in Allergic DiseasesLorenzo Cosmi, Francesco Liotta, Laura Maggi, et al.
Current Opinion in Allergy and Clinical Immunology|October 5, 2021
Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthmaLorenzo Salvati, Laura Maggi, Francesco Annunziato, et al.
Biomedicines|November 11, 2022
Therapeutical Targets in Allergic InflammationLorenzo Salvati, Francesco Liotta, Francesco Annunziato, et al.
Cancers|November 25, 2020
Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?Enrico Maggi, Irene Veneziani, Lorenzo Moretta, et al.
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
European Journal of Immunology|April 8, 2017
Th17 and Treg lymphocytes as cellular biomarkers of disease activity in Granulomatosis with PolyangiitisLorenzo Cosmi
American Journal of Respiratory and Critical Care Medicine|May 6, 2017
Group 2 Innate Lymphoid Cells Are the Earliest Recruiters of Eosinophils in Lungs of Patients with Allergic AsthmaLorenzo Cosmi, Francesco Annunziato
International Journal of Molecular Sciences|October 13, 2021
From Emollients to Biologicals: Targeting Atopic DermatitisLorenzo Salvati, Lorenzo Cosmi, Francesco Annunziato
Current Opinion in HIV and AIDS|June 15, 2010
Human and murine Th17Francesco Annunziato, Lorenzo Cosmi, Sergio Romagnani
Journal of Psychosomatic Research|October 16, 2025
The fibromyalgia black boxSara Ceccatelli, Lorenzo Cosmi, Fiammetta Cosci
Current Opinion in Allergy and Clinical Immunology|November 25, 2015
Th17 regulating lower airway diseaseLorenzo Cosmi, Francesco Liotta, Francesco Annunziato
Current Allergy and Asthma Reports|September 13, 2017
Role of Type 2 Innate Lymphoid Cells in Allergic DiseasesLorenzo Cosmi, Francesco Liotta, Laura Maggi, et al.
Current Opinion in Allergy and Clinical Immunology|October 5, 2021
Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthmaLorenzo Salvati, Laura Maggi, Francesco Annunziato, et al.
Biomedicines|November 11, 2022
Therapeutical Targets in Allergic InflammationLorenzo Salvati, Francesco Liotta, Francesco Annunziato, et al.
Cancers|November 25, 2020
Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?Enrico Maggi, Irene Veneziani, Lorenzo Moretta, et al.
Pageof 14